Synageva BioPharmaâ„¢ Joins NORD, EURORDIS, and The Global Genes Project in Support of Rare Disease Day 2014

[Business Wire] – Synageva BioPharma Corp. , a biopharmaceutical company developing therapeutic products for rare diseases, joins the National Organization for Rare Disorders more

View todays social media effects on GEVA

View the latest stocks trending across Twitter. Click to view dashboard

See who Synageva is hiring next, click here to view